As sustainability becomes more of a business imperative than ever, industries are facing serious scrutiny for their carbon dioxide emissions. One commonly cited statistic [1] about pharma, often mentioned in hushed tones, is that the sector produces around 55% more CO2 than the automotive industry. This refrain may have been the motivation pharma needs to address its role in the climate crisis more urgently, but the results of this drive for pharmaceutical sustainability will define the industry’s future.
As regulatory scrutiny intensifies and stakeholders demand greater accountability, green pharma manufacturing is becoming increasingly widespread, with companies embracing sustainable packaging and carbon-neutral logistics solutions as standard practice. Here, we’ll explore the measures already being taken to improve pharma sustainability, and offer a vision of what the longer-term results of this transformation might look like.


